1.Characterization of nucleohistone and nucleoprotamine components in the mature human sperm nucleus.
Yan LI ; Claudia LALANCETTE ; David MILLER ; Stephen A KRAWETZ
Asian Journal of Andrology 2008;10(4):535-541
AIMTo simultaneously determine the localization of histones and protamines within human sperm nuclei.
METHODSImmunofluorescence of the core histones and protamines and fluorescence in situ hybridization of the telomere region of chromosome 16 was assessed in decondensed human sperm nuclei.
RESULTSImmunofluorescent localization of histones, protamine 1 (PRM1) and protamine 2 (PRM2) along with fluorescence in situ hybridization localization of chromosome 16 telomeric sequences revealed a discrete distribution in sperm nuclei. Histones localized to the posterior ring region (i.e. the sperm nuclear annulus), whereas PRM1 and PRM2 appeared to be dispersed throughout the entire nucleus.
CONCLUSIONThe co-localization of the human core sperm histones with the telomeric regions of chromosome 16 is consistent with the reorganization of specific non-protamine regions into a less compacted state.
Cell Nucleus ; metabolism ; Chromosomes, Human, Pair 16 ; metabolism ; Histones ; metabolism ; Humans ; Male ; Protamines ; metabolism ; Spermatozoa ; metabolism ; Telomere ; metabolism
2.Concordant and Discordant Cardiac Magnetic Resonance Imaging Delayed Hyperenhancement Patterns in Patients with Ischemic and Non-Ischemic Cardiomyopathy.
Eun Kyoung KIM ; Sung A CHANG ; Jin Oh CHOI ; James GLOCKNER ; Brian SHAPIRO ; Yeon Hyeon CHOE ; Nowell FINE ; Shin Yi JANG ; Sung Mok KIM ; Wayne MILLER ; Sang Chol LEE ; Jae K OH
Korean Circulation Journal 2016;46(1):41-47
BACKGROUND AND OBJECTIVES: The diagnosis of ischemic (ICM) and non-ischemic cardiomyopathy (NICM) is conventionally determined by the presence or absence of coronary artery disease (CAD) in the setting of a reduced left systolic function. However the presence of CAD may not always indicate that the actual left ventricular (LV) dysfunction mechanism is ischemia, as other non-ischemic etiologies can be responsible. We investigated patterns of myocardial fibrosis using delayed hyperenhancement (DHE) on cardiac magnetic resonance (CMR) in ICM and NICM. SUBJECTS AND METHODS: Patients with systolic heart failure who underwent a CMR were prospectively analyzed. The heart failure diagnosis was based on the modified Framingham criteria and LVEF <35%. LV dysfunction was classified as ICM or NICM based on coronary anatomy. RESULTS: A total of 101 subjects were analyzed; 34 were classified as ICM and 67 as NICM. The DHE pattern was concordant with the conventional diagnosis in 27 (79.4%) of the patients with ICM and 62 (92.5%) of the patients with NCIM. A discordant NICM DHE pattern was present in 8.8% of patients with ICM, and an ICM pattern was detected 6.0% of the patients with NICM. Furthermore, 11.8% of the patients with ICM and 1.5% of those with NICM demonstrated a mixed pattern. CONCLUSION: A subset of patients conventionally diagnosed with ICM or NICM based on coronary anatomy demonstrated a discordant or mixed DHE pattern. CMR-DHE imaging can be helpful to determine the etiology of heart failure in patients with persistent LV systolic dysfunction.
Cardiac Imaging Techniques
;
Cardiomyopathies*
;
Coronary Artery Disease
;
Diagnosis
;
Fibrosis
;
Heart Failure
;
Heart Failure, Systolic
;
Humans
;
Ischemia
;
Magnetic Resonance Imaging*
;
Prospective Studies
3.Tet2 Regulates Osteoclast Differentiation by Interacting with Runx1 and Maintaining Genomic 5-Hydroxymethylcytosine (5hmC).
Yajing CHU ; Zhigang ZHAO ; David Wayne SANT ; Ganqian ZHU ; Sarah M GREENBLATT ; Lin LIU ; Jinhuan WANG ; Zeng CAO ; Jeanette Cheng THO ; Shi CHEN ; Xiaochen LIU ; Peng ZHANG ; Jaroslaw P MACIEJEWSKI ; Stephen NIMER ; Gaofeng WANG ; Weiping YUAN ; Feng-Chun YANG ; Mingjiang XU
Genomics, Proteomics & Bioinformatics 2018;16(3):172-186
As a dioxygenase, Ten-Eleven Translocation 2 (TET2) catalyzes subsequent steps of 5-methylcytosine (5mC) oxidation. TET2 plays a critical role in the self-renewal, proliferation, and differentiation of hematopoietic stem cells, but its impact on mature hematopoietic cells is not well-characterized. Here we show that Tet2 plays an essential role in osteoclastogenesis. Deletion of Tet2 impairs the differentiation of osteoclast precursor cells (macrophages) and their maturation into bone-resorbing osteoclasts in vitro. Furthermore, Tet2 mice exhibit mild osteopetrosis, accompanied by decreased number of osteoclasts in vivo. Tet2 loss in macrophages results in the altered expression of a set of genes implicated in osteoclast differentiation, such as Cebpa, Mafb, and Nfkbiz. Tet2 deletion also leads to a genome-wide alteration in the level of 5-hydroxymethylcytosine (5hmC) and altered expression of a specific subset of macrophage genes associated with osteoclast differentiation. Furthermore, Tet2 interacts with Runx1 and negatively modulates its transcriptional activity. Our studies demonstrate a novel molecular mechanism controlling osteoclast differentiation and function by Tet2, that is, through interactions with Runx1 and the maintenance of genomic 5hmC. Targeting Tet2 and its pathway could be a potential therapeutic strategy for the prevention and treatment of abnormal bone mass caused by the deregulation of osteoclast activities.
5-Methylcytosine
;
analogs & derivatives
;
chemistry
;
metabolism
;
Animals
;
Cell Differentiation
;
Cells, Cultured
;
Core Binding Factor Alpha 2 Subunit
;
genetics
;
metabolism
;
DNA-Binding Proteins
;
physiology
;
Genome
;
Genomics
;
Mice
;
Mice, Knockout
;
Osteoclasts
;
cytology
;
metabolism
;
Proto-Oncogene Proteins
;
physiology